Treatment Changes among Users of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation.
about
Standard and reduced doses of dabigatran, rivaroxaban, and apixaban for stroke prevention in atrial fibrillation: a nationwide cohort study.Switching, Adverse Effects and Use of Over-the-Counter Analgesics among Users of Oral Anticoagulants: A Pharmacy-based Survey.High number of newly initiated direct oral anticoagulant users switch to alternate anticoagulant therapy.Use of direct oral anticoagulants in the first year after market entry of edoxaban: A Danish nationwide drug utilization study.Trends in use of warfarin and direct oral anticoagulants in atrial fibrillation in Norway, 2010 to 2015.
P2860
Treatment Changes among Users of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Treatment Changes among Users ...... ulants in Atrial Fibrillation.
@en
type
label
Treatment Changes among Users ...... ulants in Atrial Fibrillation.
@en
prefLabel
Treatment Changes among Users ...... ulants in Atrial Fibrillation.
@en
P2093
P2860
P356
P1476
Treatment Changes among Users ...... ulants in Atrial Fibrillation.
@en
P2093
Birgitte Klindt Poulsen
Erik Lerkevang Grove
Lotte Rasmussen
Maja Hellfritzsch
Steen Elkjaer Husted
Søren Paaske Johnsen
P2860
P304
P356
10.1111/BCPT.12664
P577
2016-08-31T00:00:00Z